Effect of Rebamipide and Diquafosol Ophthalmic Suspension on Ocular Surface for Dry Eye After Penetrating Keratoplasty: Randomized Controlled Trials.

Effect of Rebamipide and Diquafosol Ophthalmic Suspension on Ocular Surface for Dry Eye After Penetrating Keratoplasty: Randomized Controlled Trials. - Ocular Surface after Penetrating Keratoplasty

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019983

Enrollment

Registered

2015-11-29

Start date

2015-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eyes after Penetrating Keratoplasty

Interventions

Rebamipide Ophthalmic Suspension: 4 times a day during 4 weeks after treatment Diquafosol Ophthalmic Suspension: 4 times a day during 4 weeks after treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Dry eyes after penetrating keratoplasy.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Ocular surface parameters and subjective symptom before and after ophthalmic solutions	—

Countries

Japan

Contacts

Public ContactHidenaga Kobashi

University of Kitasato School of Medicine Department of Ophthalmology

himon@hotmail.co.jp+81-42-778-9012

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026